G I Murray

1.5k total citations
25 papers, 1.2k citations indexed

About

G I Murray is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, G I Murray has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in G I Murray's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Molecular Biology Techniques and Applications (3 papers). G I Murray is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Molecular Biology Techniques and Applications (3 papers). G I Murray collaborates with scholars based in United Kingdom, United States and India. G I Murray's co-authors include M.D. Burke, William T. Melvin, Howard L. McLeod, Judith McKay, Stephanie Curran, Bertrand Rochat, William D. Figg, Simon Payne, N E Haites and George King and has published in prestigious journals such as FEBS Letters, British Journal of Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

G I Murray

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G I Murray United Kingdom 18 525 493 404 210 160 25 1.2k
Patrick H. Rooney United Kingdom 16 512 1.0× 292 0.6× 236 0.6× 248 1.2× 124 0.8× 21 980
Ming‐Derg Lai Taiwan 22 597 1.1× 352 0.7× 226 0.6× 208 1.0× 71 0.4× 48 1.3k
Araba A. Adjei United States 19 616 1.2× 377 0.8× 209 0.5× 145 0.7× 335 2.1× 32 1.3k
Matthew A. Leff United States 13 782 1.5× 265 0.5× 142 0.4× 447 2.1× 158 1.0× 14 1.2k
Mitsunori Sasa Japan 24 564 1.1× 785 1.6× 399 1.0× 480 2.3× 491 3.1× 87 1.7k
Jun-ichi Sawada Japan 20 696 1.3× 751 1.5× 243 0.6× 92 0.4× 82 0.5× 42 1.4k
Miriam Falzon United States 24 1.0k 1.9× 706 1.4× 101 0.3× 144 0.7× 197 1.2× 70 1.7k
Eric C. Dietze United States 20 663 1.3× 456 0.9× 109 0.3× 288 1.4× 200 1.3× 44 1.3k
Kiyoko Shinkai Japan 23 1.0k 2.0× 269 0.5× 114 0.3× 152 0.7× 72 0.5× 41 1.4k
Matthew J. Sikora United States 20 508 1.0× 415 0.8× 146 0.4× 336 1.6× 325 2.0× 40 1.1k

Countries citing papers authored by G I Murray

Since Specialization
Citations

This map shows the geographic impact of G I Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G I Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G I Murray more than expected).

Fields of papers citing papers by G I Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G I Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G I Murray. The network helps show where G I Murray may publish in the future.

Co-authorship network of co-authors of G I Murray

This figure shows the co-authorship network connecting the top 25 collaborators of G I Murray. A scholar is included among the top collaborators of G I Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G I Murray. G I Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graf, Nicole, Mairi H McLean, Silvia Capellino, et al.. (2011). Loss of sensory and noradrenergic innervation in benign colorectal adenomatous polyps – a putative role of semaphorins 3F and 3A. Neurogastroenterology & Motility. 24(2). 120–120. 7 indexed citations
2.
Cruickshank, Margaret, et al.. (2005). Human papillomavirus 16 infection in adenocarcinoma of the cervix. British Journal of Cancer. 93(11). 1301–1304. 22 indexed citations
3.
Lawrie, Laura, S. R. Dundas, Stephanie Curran, & G I Murray. (2004). Liver fatty acid binding protein expression in colorectal neoplasia. British Journal of Cancer. 90(10). 1955–1960. 54 indexed citations
4.
Tayeb, Mohammed T., Caroline Clark, N E Haites, et al.. (2003). CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia. British Journal of Cancer. 88(6). 928–932. 46 indexed citations
5.
McFadyen, Morag, Margaret Cruickshank, I.D. Miller, et al.. (2001). Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. British Journal of Cancer. 85(2). 242–246. 126 indexed citations
6.
McKay, Judith, et al.. (2000). Cyclin D1 protein expression and gene polymorphism in colorectal cancer. International Journal of Cancer. 88(1). 77–81. 110 indexed citations
7.
McKay, Judith, Jacinta Douglas, Val G. Ross, et al.. (2000). Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.. PubMed. 6(3). 1113–8. 50 indexed citations
8.
McLeod, H. L., et al.. (1998). Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. British Journal of Cancer. 77(3). 461–465. 90 indexed citations
9.
Murray, G I, et al.. (1998). Enhanced expression of cytochrome P450 in stomach cancer. British Journal of Cancer. 77(7). 1040–1044. 41 indexed citations
10.
Duncan, Margaret E., Jonathan P. Richardson, G I Murray, William T. Melvin, & John E. Fothergill. (1998). Human matrix metalloproteinase‐9 : activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. European Journal of Biochemistry. 258(1). 37–43. 49 indexed citations
11.
King, George, et al.. (1997). A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. The Journal of Pathology. 183(2). 237–241. 92 indexed citations
12.
Ekins, Sean, John A. Williams, G I Murray, et al.. (1996). Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices.. Drug Metabolism and Disposition. 24(9). 990–995. 35 indexed citations
13.
Murray, G I & M.D. Burke. (1995). Immunohistochemistry of drug-metabolizing enzymes. Biochemical Pharmacology. 50(7). 895–903. 30 indexed citations
14.
Ekins, Sean, et al.. (1995). Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.. Drug Metabolism and Disposition. 23(11). 1274–1279. 53 indexed citations
15.
McKay, Judith, William T. Melvin, A K Ah-See, et al.. (1995). Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Letters. 374(2). 270–272. 117 indexed citations
16.
Henshaw, Richard C., et al.. (1992). Multiple fetal anomalies in the first trimester; detection using transvaginal ultrasound and therapeutic abortion using mifepristone (RU486) in conjunction with gemeprost vaginal pessaries. BJOG An International Journal of Obstetrics & Gynaecology. 99(3). 258–264. 1 indexed citations
17.
Murray, G I. (1992). Enzyme histochemistry and immunohistochemistry with freeze-dried or freeze-substituted resin-embedded tissue. The Histochemical Journal. 24(7). 399–408. 11 indexed citations
18.
Murray, G I, P.J.K. Paterson, S. W. B. Ewen, & William T. Melvin. (1992). In situ hybridisation of albumin mRNA in normal liver and hepatocellular carcinoma with a digoxigenin labelled oligonucleotide probe.. Journal of Clinical Pathology. 45(1). 21–24. 26 indexed citations
19.
Murray, G I, et al.. (1991). Expression of cytochrome P450IA in breast cancer. British Journal of Cancer. 63(6). 1021–1023. 31 indexed citations
20.
Murray, G I, M.D. Burke, & S. W. B. Ewen. (1989). Enzyme histochemistry on freeze-dried, resin-embedded tissue.. Journal of Histochemistry & Cytochemistry. 37(5). 643–652. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick H. Rooney Breakdown of academic impact, for papers by Ming‐Derg Lai Breakdown of academic impact, for papers by Araba A. Adjei Breakdown of academic impact, for papers by Matthew A. Leff Breakdown of academic impact, for papers by Mitsunori Sasa Breakdown of academic impact, for papers by Jun-ichi Sawada Breakdown of academic impact, for papers by Miriam Falzon Breakdown of academic impact, for papers by Eric C. Dietze Breakdown of academic impact, for papers by Kiyoko Shinkai Breakdown of academic impact, for papers by Matthew J. Sikora
Rankless by CCL
2026